|
|
Vaccine Detail
|
OCDC and NeoDC Vaccine |
| Vaccine Information |
- Vaccine Name: OCDC and NeoDC Vaccine
- Target Pathogen: Cancer
- Target Disease: Cancer
- Type: whole cell cancer vaccine
- Status: Clinical trial
- Host Species for Licensed Use: None
- Antigen: personal neoantigen (NCT05317325)
- Immunization Route: subcutaneous injection
- Description: Autologous DCs are pulsed with HOCl-oxidized autologous tumor lysate (OCDC) and administered in prime phase, and a personal neoantigen-sensitized DC(NeoDC) vaccine is administered in the boost phase for Esophageal Squamous Cell Carcinoma. (NCT05317325)
|
| Host Response |
|
|
| References |
NCT05317325: A Translational Study of Tumor Antigen-pulsed DC Vaccine for ESCC [https://clinicaltrials.gov/study/NCT05317325]
|
|
